✦ LIBER ✦

Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis

✍ Scribed by Per Soelberg Sørensen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer risk and impact of disease-modify

✍ Lebrun, C.; Debouverie, M.; Vermersch, P.; Clavelou, P.; Rumbach, L.; de Seze, J 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 132 KB

Treatment Patterns in Disease-Modifying

✍ Bonafede, Machaon M.; Johnson, Barbara H; Wenten, Madé; Watson, Crystal 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Adherence to disease-modifying therapies

✍ Ožura, Ana; Kovač, Lea; Šega, Saša 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 657 KB

PND21 FIRST USE OF DISEASE-MODIFYING DRU

✍ DM Meletiche; C Kozma; M Dickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

The UK patient experience of relapse in

✍ Duddy, Martin; Lee, Martin; Pearson, Owen; Nikfekr, Esmaeil; Chaudhuri, Abhijit; 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 484 KB

Balancing Risks and Benefits of Therapy

✍ Hay, Annette E.; Meyer, Ralph M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 309 KB